Login Register Cart 0
Generic placeholder image

Current Pediatric Reviews

Editor-in-Chief

ISSN (Print): 1573-3963
ISSN (Online): 1875-6336

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Treatment of Allergic Rhinitis in Clinical Practice

Author(s): Maria Angela Tosca, Chiara Trincianti, Matteo Naso, Valentina Nosratian and Giorgio Ciprandi*

Volume 20, Issue 3, 2024

Published on: 18 September, 2023

Page: [271 - 277] Pages: 7

DOI: 10.2174/1573396320666230912103108

Price: $65

Abstract

Allergic rhinitis is a prevalent condition among children, with its occurrence reaching up to 40% of the general population in some geographical areas. A type 2 immunity sustains allergic rhinitis. Consequently, type 2 inflammation leads to eosinophilic infiltrate of the nasal mucosa. Allergic inflammation causes the symptom occurrence. Typical nasal symptoms include nasal itching, sneezing, watery rhinorrhea, and nasal congestion. Nasal congestion depends on vasodilation and increased mucus production. These conditions result in nasal obstruction. Nasal obstruction is closely associated with type 2 inflammation. Allergic rhinitis usually occurs in association with other allergic conditions, in particular allergic conjunctivitis and asthma. The effective management of allergic rhinitis involves avoiding triggering allergens and employing pharmacological treatments as per ARIA guidelines. These treatments may include intranasal/oral antihistamines or/and nasal corticosteroids. In particular, antihistamines are particularly indicated for symptoms consequent to mediators’ release, mainly concerning histamine. These histamine-dependent symptoms include itching, sneezing, and rhinorrhea. Nasal obstruction, being associated with inflammation, is responsive to corticosteroids, administered mostly intranasally. The fixed combination of a topical antihistamine plus a topical corticosteroid is very effective, but is indicated for adolescents only. However, nasal lavage is safe, cheap, and adequate, thus its use is prevalent. Namely, nasal lavage allows to remove secretions, allergens, mediators. In addition, hypertonic solutions exert a decongestant activity. On the other hand, the allergen-specific immunotherapy is still the only causal treatment. Nutraceuticals have also been used to relieve symptoms. The objective of this review is to explore and compare the traditional and new therapeutic approaches for pollen-induced allergic rhinitis in children.

Keywords: Rhinitis, infections, allergy, children, nasal lavage, antihistamines, intranasal corticosteroids, allergen-specific immunotherapy, nutraceuticals.

« Previous Next »
Graphical Abstract

[1]
Wever C. The nasal airway: A critical review. Facial Plast Surg 2016; 32(1): 017-21.
[http://dx.doi.org/10.1055/s-0035-1570323] [PMID: 26862959]
[2]
Walker A, Surda P, Rossiter M, Little S. Nasal function and dysfunction in exercise. J Laryngol Otol 2016; 130(5): 431-4.
[http://dx.doi.org/10.1017/S0022215116000128] [PMID: 27095550]
[3]
Hamilton GS III. The external nasal valve. Facial Plast Surg Clin North Am 2017; 25(2): 179-94.
[http://dx.doi.org/10.1016/j.fsc.2016.12.010] [PMID: 28340649]
[4]
Bansil R, Turner BS. The biology of mucus: Composition, synthesis and organization. Adv Drug Deliv Rev 2018; 124: 3-15.
[http://dx.doi.org/10.1016/j.addr.2017.09.023] [PMID: 28970050]
[5]
Taherali F, Varum F, Basit AW. A slippery slope: On the origin, role and physiology of mucus. Adv Drug Deliv Rev 2018; 124: 16-33.
[http://dx.doi.org/10.1016/j.addr.2017.10.014] [PMID: 29108861]
[6]
Klain A, Indolfi C, Dinardo G, et al. Comparing available treatments for pollen-induced allergic rhinitis in children. Expert Rev Clin Immunol 2022; 18(8): 835-43.
[http://dx.doi.org/10.1080/1744666X.2022.2093188] [PMID: 35726790]
[7]
Rochereau N, Pavot V, Verrier B, et al. Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity. J Allergy Clin Immunol 2016; 137(1): 214-222.e2.
[http://dx.doi.org/10.1016/j.jaci.2015.07.042] [PMID: 26414879]
[8]
Pizzolla A, Wang Z, Groom JR, et al. Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells. Proc Natl Acad Sci 2017; 114(20): 5225-30.
[http://dx.doi.org/10.1073/pnas.1620194114] [PMID: 28461487]
[9]
Trincianti C, Tosca MA, Ciprandi G. Updates in the diagnosis and practical management of allergic rhinitis. Expert Rev Clin Pharmacol 2023; 16(7): 669-76.
[http://dx.doi.org/10.1080/17512433.2023.2225770] [PMID: 37314373]
[10]
Sozansky J, Houser SM. The physiological mechanism for sensing nasal airflow: A literature review. Int Forum Allergy Rhinol 2014; 4(10): 834-8.
[http://dx.doi.org/10.1002/alr.21368] [PMID: 25079504]
[11]
Ciprandi G, Mora F, Cassano M, Gallina AM, Mora R. Visual analog scale (VAS) and nasal obstruction in persistent allergic rhinitis. Otolaryngol Head Neck Surg 2009; 141(4): 527-9.
[http://dx.doi.org/10.1016/j.otohns.2009.06.083] [PMID: 19786224]
[12]
Birchenough GMH, Johansson ME, Gustafsson JK, Bergström JH, Hansson GC. New developments in goblet cell mucus secretion and function. Mucosal Immunol 2015; 8(4): 712-9.
[http://dx.doi.org/10.1038/mi.2015.32] [PMID: 25872481]
[13]
Ciprandi G, Marseglia GL, Klersy C, Tosca MA. Relationships between allergic inflammation and nasal airflow in children with persistent allergic rhinitis due to mite sensitization. Allergy 2005; 60(7): 957-60.
[http://dx.doi.org/10.1111/j.1398-9995.2005.00664.x] [PMID: 15932388]
[14]
Gelardi M, Maselli Del Giudice A, Candreva T, et al. Nasal resistance and allergic inflammation depend on allergen type. Int Arch Allergy Immunol 2006; 141(4): 384-9.
[http://dx.doi.org/10.1159/000095465] [PMID: 16943677]
[15]
Ciprandi G, Cirillo I. The lower airway pathology of rhinitis. J Allergy Clin Immunol 2006; 118(5): 1105-9.
[http://dx.doi.org/10.1016/j.jaci.2006.05.010] [PMID: 17088136]
[16]
Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet 2014; 383(9918): 736-47.
[http://dx.doi.org/10.1016/S0140-6736(13)60734-5] [PMID: 23910433]
[17]
King D. What role for saline nasal irrigation? Drug Ther Bull 2019; 57(4): 56-9.
[http://dx.doi.org/10.1136/dtb.2018.000023] [PMID: 30858292]
[18]
Gelardi M, Taliente S, Piccininni K, Silvestre G, Quaranta N, Ciprandi G. Nasal irrigation with Nasir® in children: A preliminary experience on nasal cytology. J Biol Regul Homeost Agents 2016; 30(4): 1125-30.
[PMID: 28078863]
[19]
Piper KJ, Foster H, Susanto D, Maree CL, Thornton SD, Cobbs CS. Fatal Balamuthia mandrillaris brain infection associated with improper nasal lavage. Int J Infect Dis 2018; 77: 18-22.
[http://dx.doi.org/10.1016/j.ijid.2018.09.013] [PMID: 30243910]
[20]
Fandino A, Douglas R. A historical review of the evolution of nasal lavage systems. J Laryngol Otol 2021; 135(2): 110-6.
[http://dx.doi.org/10.1017/S002221512100030X] [PMID: 33563344]
[21]
Principi N, Esposito S. Nasal irrigation: An imprecisely defined medical procedure. Int J Environ Res Public Health 2017; 14(5): 516.
[http://dx.doi.org/10.3390/ijerph14050516] [PMID: 28492494]
[22]
Halawi AM, Smith SS, Chandra RK. Chronic rhinosinusitis: Epidemiology and cost. Allergy Asthma Proc 2013; 34(4): 328-34.
[http://dx.doi.org/10.2500/aap.2013.34.3675] [PMID: 23883597]
[23]
Head K, Chong LY, Piromchai P, et al. Systemic and topical antibiotics for chronic rhinosinusitis. Cochrane Libr 2016; 2016(4): CD011994.
[http://dx.doi.org/10.1002/14651858.CD011994.pub2] [PMID: 27113482]
[24]
Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): Adult sinusitis. Otolaryngol Head Neck Surg 2015; 152(2) (Suppl.): S1-S39.
[PMID: 25832968]
[25]
Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev 2007; 3(3): CD006394.
[http://dx.doi.org/10.1002/14651858.CD006394.pub2] [PMID: 17636843]
[26]
Rudmik L, Soler ZM. Medical therapies for adult chronic sinusitis: A systematic review. JAMA 2015; 314(9): 926-39.
[http://dx.doi.org/10.1001/jama.2015.7544] [PMID: 26325561]
[27]
Little P, Stuart B, Mullee M, et al. Effectiveness of steam inhalation and nasal irrigation for chronic or recurrent sinus symptoms in primary care: A pragmatic randomized controlled trial. CMAJ 2016; 188(13): 940-9.
[http://dx.doi.org/10.1503/cmaj.160362] [PMID: 27431306]
[28]
Rudmik L, Soler ZM, Orlandi RR, et al. Early postoperative care following endoscopic sinus surgery: An evidence-based review with recommendations. Int Forum Allergy Rhinol 2011; 1(6): 417-30.
[http://dx.doi.org/10.1002/alr.20072] [PMID: 22144050]
[29]
Liu L, Pan M, Li Y, Tan G, Yang Y. Efficacy of nasal irrigation with hypertonic saline on chronic rhinosinusitis: systematic review and meta-analysis. Rev Bras Otorrinolaringol 2020; 86(5): 639-46.
[PMID: 32534983]
[30]
Ah-See KW, Evans AS. Sinusitis and its management. BMJ 2007; 334(7589): 358-61.
[http://dx.doi.org/10.1136/bmj.39092.679722.BE] [PMID: 17303885]
[31]
Hermelingmeier KE, Weber RK, Hellmich M, Heubach CP, Mösges R. Nasal irrigation as an adjunctive treatment in allergic rhinitis: A systematic review and meta-analysis. Am J Rhinol Allergy 2012; 26(5): e119-25.
[http://dx.doi.org/10.2500/ajra.2012.26.3787] [PMID: 23168142]
[32]
Head K, Snidvongs K, Glew S, et al. Saline irrigation for allergic rhinitis. Cochrane Database Syst Rev 2018; 6(6): CD012597.
[http://dx.doi.org/10.1002/14651858.CD012597.pub2]
[33]
Wang Y, Jin L, Liu SX, Fan K, Qin ML, Yu SQ. Role of nasal saline irrigation in the treatment of allergic rhinitis in children and adults: A systematic analysis. Allergol Immunopathol 2020; 48(4): 360-7.
[http://dx.doi.org/10.1016/j.aller.2020.01.002] [PMID: 32331798]
[34]
King D, Mitchell B, Williams CP, Spurling GKP. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Libr 2015; 2015(4): CD006821.
[http://dx.doi.org/10.1002/14651858.CD006821.pub3] [PMID: 25892369]
[35]
Šlapak I, Skoupá J, Strnad P, Horník P. Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children. Arch Otolaryngol Head Neck Surg 2008; 134(1): 67-74.
[http://dx.doi.org/10.1001/archoto.2007.19] [PMID: 18209140]
[36]
Velentza L, Maridaki Z, Blana E, Miligkos M. Antihistamines in the management of pediatric allergic rhinitis: A systematic review. Paediatr Drugs 2020; 22(6): 673-83.
[http://dx.doi.org/10.1007/s40272-020-00419-x] [PMID: 32936412]
[37]
Fitzsimons R, van der Poel LA, Thornhill W, du Toit G, Shah N, Brough HA. Antihistamine use in children. Arch Dis Child Educ Pract Ed 2015; 100(3): 122-31.
[http://dx.doi.org/10.1136/archdischild-2013-304446] [PMID: 25147323]
[38]
Kaliner MA, Berger WE, Ratner PH, Siegel CJ. The efficacy of intranasal antihistamines in the treatment of allergic rhinitis. Ann Allergy Asthma Immunol 2011; 106(2) (Suppl.): S6-S11.
[http://dx.doi.org/10.1016/j.anai.2010.08.010] [PMID: 21277531]
[39]
Church M, Church D. Pharmacology of antihistamines. Indian J Dermatol 2013; 58(3): 219-24.
[http://dx.doi.org/10.4103/0019-5154.110832] [PMID: 23723474]
[40]
Shah SR, Nayak A, Ratner P, Roland P, Michael Wall G. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergie rhinitis: A phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults. Clin Ther 2009; 31(1): 99-107.
[http://dx.doi.org/10.1016/j.clinthera.2009.01.016] [PMID: 19243710]
[41]
Yonekura S, Okamoto Y, Sakurai D, et al. Efficacy of desloratadine and levocetirizine in patients with cedar pollen-induced allergic rhinitis: A randomized, double-blind study. Int Arch Allergy Immunol 2019; 180(4): 274-83.
[http://dx.doi.org/10.1159/000503065] [PMID: 31618733]
[42]
Day JH, Briscoe MP, Rafeiro E, Ratz JD. Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU). Int J Clin Pract 2004; 58(2): 109-18.
[http://dx.doi.org/10.1111/j.1368-5031.2004.0117.x] [PMID: 15055856]
[43]
Juel-Berg N, Darling P, Bolvig J, et al. Intranasal corticosteroids compared with oral antihistamines in allergic rhinitis: A systematic review and meta-analysis. Am J Rhinol Allergy 2017; 31(1): e19-28.
[http://dx.doi.org/10.2500/ajra.2016.30.4397] [PMID: 28234147]
[44]
Yamamoto H, Yonekura S, Sakurai D, et al. Using an environmental challenge chamber, comparing nasal steroid with antihistamine in prophylactic treatment against pollinosis. Allergy Asthma Proc 2012; 33(5): 397-403.
[http://dx.doi.org/10.2500/aap.2012.33.3594] [PMID: 23026181]
[45]
Bédard A, Basagaña X, Anto JM, et al. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study. J Allergy Clin Immunol 2019; 144(1): 135-143.e6.
[http://dx.doi.org/10.1016/j.jaci.2019.01.053] [PMID: 30951790]
[46]
Devillier P, Dreyfus JF, Demoly P, Calderón MA. A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis. BMC Med 2014; 12(1): 71.
[http://dx.doi.org/10.1186/1741-7015-12-71] [PMID: 24885894]
[47]
Wang C, Zhang L. Specific immunotherapy for allergic rhinitis in children. Curr Opin Otolaryngol Head Neck Surg 2014; 22(6): 487-94.
[http://dx.doi.org/10.1097/MOO.0000000000000101] [PMID: 25207858]
[48]
Matricardi PM, Kuna P, Panetta V, Wahn U, Narkus A. Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: A comparison based on meta-analyses. J Allergy Clin Immunol 2011; 128(4): 791-799.e6.
[http://dx.doi.org/10.1016/j.jaci.2011.03.049] [PMID: 21620452]
[49]
Bousquet J, Pfaar O, Agache I, et al. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy. Clin Transl Allergy 2021; 11(4): e12014.
[http://dx.doi.org/10.1002/clt2.12014] [PMID: 34136127]
[50]
Mainardi T, Kapoor S, Bielory L. Complementary and alternative medicine: Herbs, phytochemicals and vitamins and their immunologic effects. J Allergy Clin Immunol 2009; 123(2): 283-294.e10.
[http://dx.doi.org/10.1016/j.jaci.2008.12.023] [PMID: 19203652]
[51]
El-Qutob López D. New methods of prevention and treatment of allergic diseases. Recent Pat Inflamm Allergy Drug Discov 2012; 6(1): 46-64.
[http://dx.doi.org/10.2174/187221312798889257] [PMID: 22022924]
[52]
Derebery MJ, Dicpinigaitis PV. New horizons: Current and potential future self-treatments for acute upper respiratory tract conditions. Postgrad Med 2013; 125(1): 82-96.
[http://dx.doi.org/10.3810/pgm.2013.01.2605] [PMID: 23391674]
[53]
Marseglia GL, Licari A, Ciprandi G. A polycentric, randomized, double blind, parallel-group, placebo-controlled study on Lertal®, a multicomponent nutraceutical, as add-on treatment in children with allergic rhinoconjunctivitis: Phase I during active treatment. J Biol Regul Homeost Agents 2019; 33(2): 617-22.
[PMID: 30968678]
[54]
Marseglia G, Licari A, Leonardi S, et al. A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: Phase II. Ital J Pediatr 2019; 45(1): 84.
[http://dx.doi.org/10.1186/s13052-019-0678-y] [PMID: 31319883]
[55]
Miraglia Del Giudice M, Maiello N, Capristo C, et al. Resveratrol plus carboxymethyl-β-glucan reduces nasal symptoms in children with pollen-induced allergic rhinitis. Curr Med Res Opin 2014; 30(10): 1931-5.
[http://dx.doi.org/10.1185/03007995.2014.938731] [PMID: 24983742]
[56]
Aragona SE, Ciprandi G. Probiotics for the management of upper respiratory diseases. J Biol Reg Hom Ag 2020; 34(S1): 1-4.

Rights & Permissions Print Cite
Article Metrics
20
2
© 2024 Bentham Science Publishers | Privacy Policy